Group Written Exposure Therapy for PTSD
(GWET Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research shows that Written Exposure Therapy (WET) is effective for treating PTSD, with studies indicating significant symptom improvement in patients, including veterans. WET is a brief, efficient treatment that has shown similar long-term benefits to more intensive therapies like Cognitive Processing Therapy.
12345Written Exposure Therapy (WET) is generally considered safe for treating PTSD, as it is a brief and well-tolerated treatment with no significant safety concerns reported in studies.
12356Group Written Exposure Therapy is unique because it is a brief treatment consisting of only five sessions, requires no homework between sessions, and is designed to be efficient and tolerable, making it more accessible and easier to complete compared to other PTSD treatments that typically require more sessions.
12357Eligibility Criteria
This trial is for adults aged 18-65 with PTSD who can read and write in English. They must be able to give informed consent. It's not clear what excludes someone from participating, but typically it would involve factors that could interfere with the treatment or data collection.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend 6 weekly sessions of group Written Exposure Therapy (WET) delivered online by two therapists
Follow-up
Participants are monitored for changes in PTSD symptoms and related measures at 1-month post-treatment
Participant Groups
Group Written Exposure Therapy is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)